Kennedy Capital Management, Inc. Intercept Pharmaceuticals, Inc. Transaction History

Kennedy Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $255,301 - $350,001	-4,350 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $8,788 - $13,636	113 Added 2.67%	4,350 $346,000
Q1 2019 May 13, 2019	BUY	$91.83 - $120.68 $389,083 - $511,321	4,237 New	4,237 $474,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.